Muutke küpsiste eelistusi

E-raamat: Bacterial Resistance to Antibiotics: From Molecules to Man

Edited by , Edited by
  • Formaat: PDF+DRM
  • Ilmumisaeg: 14-Mar-2019
  • Kirjastus: Wiley-Blackwell
  • Keel: eng
  • ISBN-13: 9781119558200
  • Formaat - PDF+DRM
  • Hind: 49,34 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Raamatukogudele
  • Formaat: PDF+DRM
  • Ilmumisaeg: 14-Mar-2019
  • Kirjastus: Wiley-Blackwell
  • Keel: eng
  • ISBN-13: 9781119558200

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

AN AUTHORITATIVE SURVEY OF CURRENT RESEARCH INTO CLINICALLY USEFUL CONVENTIONAL AND NONCONVENTIONAL ANTIBIOTIC THERAPEUTICS

Pharmaceutically-active antibiotics revolutionized the treatment of infectious diseases, leading to decreased mortality and increased life expectancy. However, recent years have seen an alarming rise in the number and frequency of antibiotic-resistant "Superbugs." The Centers for Disease Control and Prevention (CDC) estimates that over two million antibiotic-resistant infections occur in the United States annually, resulting in approximately 23,000 deaths.

Despite the danger to public health, a minimal number of new antibiotic drugs are currently in development or in clinical trials by major pharmaceutical companies. To prevent reverting back to the pre-antibiotic era—when diseases caused by parasites or infections were virtually untreatable and frequently resulted in death—new and innovative approaches are needed to combat the increasing resistance of pathogenic bacteria to antibiotics.

Bacterial Resistance to Antibiotics – From Molecules to Man examines the current state and future direction of research into developing clinically-useful next-generation novel antibiotics. An internationally-recognized team of experts cover topics including glycopeptide antibiotic resistance, anti-tuberculosis agents, anti-virulence therapies, tetracyclines, the molecular and structural determinants of resistance, and more.

  • Presents a multidisciplinary approach for the optimization of novel antibiotics for maximum potency, minimal toxicity, and appropriated degradability
  • Highlights critical aspects that may relieve the problematic medical situation of antibiotic resistance
  • Includes an overview of the genetic and molecular mechanisms of antibiotic resistance
  • Addresses contemporary issues of global public health and longevity
  • Includes full references, author remarks, and color illustrations, graphs, and charts

Bacterial Resistance to Antibiotics – From Molecules to Man is a valuable source of up-to-date information for medical practitioners, researchers, academics, and professionals in public health, pharmaceuticals, microbiology, and related fields.

List of Contributors
vii
Preface ix
Foreword xiii
Ada Yonath
1 Molecular Mechanisms of Antibiotic Resistance -- Part I
1(26)
Alison J. Baylay
Laura J.V. Piddock
Mark A. Webber
2 Molecular Mechanisms of Antibiotic Resistance -- Part II
27(24)
Liam K.R. Sharkey
Alex J. O'Neill
3 Resistance to Glycopeptide Antibiotics
51(30)
Francois Lebreton
Vincent Cattoir
4 Resistance and Tolerance to Aminoglycosides
81(20)
Wendy W.K. Mok
Mark P. Brynildsen
5 Tetracyclines: Mode of Action and their Bacterial Mechanisms of Resistance
101(24)
Marilyn C. Roberts
6 Fluoroquinolone Resistance
125(38)
Karl Drlica
Xilin Zhao
Muhammad Malik
Hiroshi Hiasa
Arkady Mustaev
Robert Kerns
7 Dihydropteroate Synthase (Sulfonamides) and Dihydrofolate Reductase Inhibitors
163(10)
Clemente Capasso
Claudiu T. Supuran
8 Anti-tuberculosis Agents
173(28)
Ying Zhang
9 Multidrug Resistance
201(38)
Robert L. Marshall
Vassiliy N. Bavro
10 Anti-virulence Therapies Through Potentiating ROS in Bacteria
239(16)
Kristin J. Adolfsen
Mark P. Brynildsen
Index 255
BOYAN B. BONEV is Associate Professor in Biophysics and Structural Biology, Faculty of Medicine & Health Sciences, University of Nottingham, UK. Dr. Bonev heads the Biomembrane NMR labs and is co-Director of the Dynamic Nuclear Magnetization Facility.

NICHOLAS M. BROWN is clinical lead for medical microbiology at Addenbrooke's Hospital, Cambridge. He is previous President and current Director of Public and Professional Engagement, British Society for Antimicrobial Chemotherapy (BSAC).